All articles by Vemula Pravalika
Vemula Pravalika
Beckman Coulter and Fujirebio expand partnership to develop patient-friendly, blood-based neurodegenerative disease diagnostics
Beckman Coulter Diagnostics, a clinical diagnostics leader, and Fujirebio, a leader in neurological markers and In Vitro Diagnostic (IVD) manufacturing, today announced an expansion of their partnership focused on development, manufacturing and clinical adoption of neurodegenerative disease assays.
Microbix Unveils Test Controls for Head and Neck Cancer
HPV-related Tissue-Sample Mimics for QC of histology and PCR analyses
Thermo Fisher Scientific Launches CorEvitas Clinical Registry in Generalized Pustular Psoriasis
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of a new CorEvitas syndicated clinical registry in generalized pustular psoriasis (GPP). This registry, which is open to enrollment, is CorEvitas’ 10th syndicated disease registry and addresses an unmet need for real-world evidence (RWE) related to the clinical and patient-reported outcomes of patients with GPP.
Providence and Microsoft’s Nuance to ramp up healthcare AI innovation
The tie-up will focus on five key areas, including improving operational efficiency and in-house solution development.
CenTrak launches cloud real-time location platform for healthcare
The platform will consolidate administrative functions, facilitating better control and management for healthcare facilities.
Bio-Rad Launches Vericheck ddPCR Replication Competent Lentivirus and Replication Competent AAV Kits for Cell and Gene Therapy Production
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the recent launch of the Vericheck ddPCRTM Replication Competent Lentivirus Kit and the Vericheck ddPCR Replication Competent AAV Kit. The kits provide rapid, cost-effective solutions for the absolute quantification of replication competent lentivirus (RCL) and replication competent adeno-associated virus (RCAAV), supporting the safe and effective production of cell and gene therapies.
Coalition calls for testing to tackle threat of Antimicrobial Resistance
A new coalition of industry and health charities, led by former Health Minister, raise the alarm over missed opportunities to tackle Antimicrobial Resistance in the UK.
Bruker signs agreement to acquire ELITechGroup for $942m
The transaction excludes ELITech’s clinical chemistry business, which is being carved out.
Noul, a top On-Device AI healthcare company, joins CancerX, a cancer-fighting project led by the U.S. White House
As part of the Cancer Moonshot initiative announced at the White House, noul is delighted to announce its groundbreaking participation as a leading On-Device AI healthcare company in the private-public partnership, CancerX. Congratulations on noul’s efforts to take a step closer to global cancer conquest!
Sentara taps RhythmX AI to improve primary care with generative AI
The collaboration will focus on developing a next-generation, hyper-personalised primary care model for clinicians and patients.